June 25, 2012, Darmstadt, Germany — Merck Millipore, the Life Science division of Merck KGaA, today announced that Vincent Donovan has been appointed Head of BioPharmaceutical Process Solutions at Merck Millipore. He will assume leadership effective July 1, 2012 and be based at the company’s Bedford, Massachusetts office.
Donovan joined Millipore Corporation in 1988 and has held numerous sales leadership roles including Senior Director, North American Field Operations, Bioprocess Division, and Director of Sales, BioPharmceutical Division.
“Vin brings a global perspective and broad experience in supporting life science customers from product development through manufacturing,” noted Andrew Bulpin, Executive Vice President of Process Solutions, Merck Millipore. “I look forward to working closely with Vin to expand and reinforce Merck Millipore’s leadership in the biopharmaceutical field. I am confident that his deep expertise will reinforce our position as the premier partner to bring customers’ molecules to market.”
Donovan holds a BA from Merrimack College in Massachusetts and an MBA from Rivier College in New Hampshire.
About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany